Your browser doesn't support javascript.
loading
Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin.
Zou, Seyin; Cao, Nuo; Cheng, Du; Zheng, Rongqin; Wang, Jin; Zhu, Kangshun; Shuai, Xintao.
Afiliación
  • Zou S; Center of Biomedical Engineering, Zhongshan School of Medicine, Guangzhou Medical University, Guangzhou, China.
Int J Nanomedicine ; 7: 3823-35, 2012.
Article en En | MEDLINE | ID: mdl-22888237
ABSTRACT
A folate conjugated ternary copolymer, FA-PEG-PEI-PCL, of poly(ethylene glycol) (PEG), poly(ethylene imine) (PEI), and poly(ɛ-caprolactone) (PCL) was synthesized. The copolymer self-assembled into cationic micelles capable of co-delivering siRNA and the anticancer drug doxorubicin (DOX). This dual functional nanocarrier demonstrated low cytotoxicity and high performance in drug/siRNA delivery. Upon the codelivery of siRNA, targeting the Bcl-2 gene, and DOX, using the folate-targeted nanocarrier, DOX-induced apoptosis in the skov-3 cells overexpressing folate receptor was significantly enhanced through a mechanism of downregulating the antiapoptotic protein Bcl-2, while simultaneously upregulating the proapoptotic protein Bax. This work suggested that the combination of Bcl-2 siRNA and DOX therapies is feasible, based on our dual functional nanocarrier, which set up a good basis for a future in vivo test.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Portadores de Fármacos / Doxorrubicina / ARN Interferente Pequeño / Antineoplásicos Límite: Female / Humans Idioma: En Revista: Int J Nanomedicine Año: 2012 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Portadores de Fármacos / Doxorrubicina / ARN Interferente Pequeño / Antineoplásicos Límite: Female / Humans Idioma: En Revista: Int J Nanomedicine Año: 2012 Tipo del documento: Article País de afiliación: China